ReviewReviews in cardiovascular medicine2025
Management of Arrhythmic Mitral Valve Prolapse: Potential Impact and Current Evidence.
Review in Reviews in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mitral valve prolapse (MVP), also known as floppy mitral valve syndrome, systolic click-murmur syndrome, and billowing mitral leaflets, is a developmental anomaly caused when one or two abnormal valve leaflets are displaced into the left atrium below the mitral valve annulus during systole. MVP is observed in 2-3% of patients in the general population and is the leading cause of mitral regurgitation (MR) in developed countries. Overall, MVP is considered a benign developmental anomaly; however, evidence suggests that MVP is associated with sudden cardiac death. Thus, there have been ongoing discussions about the optimal management of this patient group, which includes both pharmacological treatment and surgical interventions. This review aimed to provide an overview of the benign and arrhythmic MVP (AMVP), its diagnostic options, and management possibilities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.